Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

Compounding 52

Compounding Sterile Compounds Omnicell Patient Care 52

Omnicell

JANUARY 10, 2023

Lisa Armburger Director, Client Success Executive, Omnicell 340B The pressures of the last year have underscored the importance of the 340B program and its impact on hospital finances. It's important to work with hospital leadership to underscore the importance of this position, and how it will drive program success.

Omnicell 40

Omnicell Hospitals Documentation 40

Omnicell

SEPTEMBER 5, 2022

the firm’s drug pricing practice is led by Bill von Oehsen, who played an instrumental role in drafting the 340B law and founded the hospital trade group 340B Health. Their counsel, Powers Law, has close to three decades of experience with the 340B program. Barbara Straub-Williams adds her significant, in-depth compliance expertise.

Hospitals 52

Hospitals 52

Omnicell

MARCH 27, 2023

The government only moved forward after hospital groups sued HRSA in 2018 over the ceiling price and CMP mandate and only after health centers and HIV and AIDS clinics sued over the ADR system. It was not until the last days of the Trump administration that HRSA finalized the ADR rules.

Omnicell 52

Omnicell Hospitals Packaging 52

Omnicell

FEBRUARY 14, 2023

The government only moved forward after hospital groups sued HRSA in 2018 over the ceiling price and CMP mandate and only after health centers and HIV and AIDS clinics sued over the ADR system. It was not until the last days of the Trump administration that HRSA finalized the ADR rules.

Omnicell 52

Omnicell Hospitals Packaging 52